[Further increase of quinolone resistance of gonococci in the Netherlands and proposal for a new surveillance].
Previous publications have indicated that between 2002 and 2003 in the Netherlands, the antimicrobial resistance in gonococci increased. Repeat measurements in 2004 and 2005 suggest a further increase in resistance ofgonococci, to quinolones in particular, from 7% in 2002 to 26% in 2005. National surveillance of gonococcal antimicrobial resistance is important for public health. In 2006 a further survey will be implemented, in which resistance data and epidemiological information on the patients are combined and collected in a project called 'Gonococcal resistance to antimicrobials surveillance' (GRAS).
Koedijk
F D H
FD
Rijksinstituut voor Volksgezondheid en Milieu (RIVM), Centrum voor Infectieziekten Epidemiologie, Postbus i, 3720 BA Bilthoven. femke.koedijk@rivm.nl
Borgen
K
K
van Loo
I H M
IH
van de Laar
M J W
MJ
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D024881:Drug Resistance, Bacterial; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D009426:Netherlands; D015363:Quinolones / Q000494:pharmacology*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015363:Quinolones